Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence

Since the publication of the RECOVERY trial, the use of glucocorticoid drugs (GC) has spread for the treatment of severe COVID-19 worldwide. However, the benefit of dexamethasone was largest in patients who received mechanical ventilation or supplemental oxygen therapy, while no benefit was found am...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarzani, Riccardo, Spannella, Francesco, Giulietti, Federico, Di Pentima, Chiara, Giordano, Piero, Giacometti, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Im - Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557262/
https://www.ncbi.nlm.nih.gov/pubmed/34718937
http://dx.doi.org/10.1007/s11739-021-02860-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557262/
https://www.ncbi.nlm.nih.gov/pubmed/34718937
http://dx.doi.org/10.1007/s11739-021-02860-3

Ejemplares similares